GENERATION BIO CO. - COMMON STOCK

Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases

06 1 2025 16:30:00 提供 Nasdaq GlobeNewswire

Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results

06 11 2024 16:05:00 提供 Nasdaq GlobeNewswire

Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress

22 10 2024 06:59:00 提供 Nasdaq GlobeNewswire

Generation Bio to Present at the 2024 Cantor Global Healthcare Conference

12 9 2024 16:05:00 提供 Nasdaq GlobeNewswire

Generation Bio Reports Second Quarter 2024 Financial Results

07 8 2024 16:05:00 提供 Nasdaq GlobeNewswire

Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference

06 8 2024 06:59:00 提供 Nasdaq GlobeNewswire

Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit

14 6 2024 06:59:00 提供 Nasdaq GlobeNewswire

Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results

13 5 2024 16:05:00 提供 Nasdaq GlobeNewswire

Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting

09 5 2024 06:59:00 提供 Nasdaq GlobeNewswire

Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

22 4 2024 17:31:01 提供 Nasdaq GlobeNewswire

Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference

02 4 2024 06:59:00 提供 Nasdaq GlobeNewswire

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

06 3 2024 16:20:00 提供 Nasdaq GlobeNewswire

Generation Bio to Present at the 2024 TD Cowen Health Care Conference

27 2 2024 06:59:00 提供 Nasdaq GlobeNewswire

Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference

03 1 2024 16:05:00 提供 Nasdaq GlobeNewswire

Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms

29 11 2023 06:59:00 提供 Nasdaq GlobeNewswire

Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results

09 11 2023 16:15:00 提供 Nasdaq GlobeNewswire

Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform

26 10 2023 06:59:00 提供 Nasdaq GlobeNewswire

Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel “Immune-Quiet” DNA

18 10 2023 06:59:16 提供 Nasdaq GlobeNewswire

Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit

19 9 2023 07:30:00 提供 Nasdaq GlobeNewswire

Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference 

03 8 2023 07:30:00 提供 Nasdaq GlobeNewswire